Resources
Posters
Publications
Webinars
Videos
Case Studies
Blog
blog
Building Better NAb Assays: A Mechanism-Driven Approach
A therapeutic protein can provoke anti-drug antibodies (ADAs) that do more than bind to the drug. Determining whether confirmed ADAs have neutralizing activity, and their clinical impact, is therefore an important part of a risk-based immunogenicity assessment.